Lung adenocarcinoma, the most common form of lung cancer worldwide, has long been studied through the lens of its malignant ...

About 25% of lung adenocarcinomas have mutations of the gene KRAS, which drives uncontrolled cell growth. In recent years, the FDA has approved two KRAS inhibitors to treat patients with KRAS ...

Lung squamous cell carcinoma, one of the two major forms of non-small cell lung cancer, remains one of the deadliest malignancies in the world. Lung cancers collectively lead global cancer mortality, ...

BOSTON — Key DNA and chromosomal and immune cell changes in early-stage lung adenocarcinoma show significant associations with outcomes, representing potentially important early predictors to guide ...

New research has revealed that perilipin 2 protein modulates aggressive cancer progression in advanced lung adenocarcinoma, the most common type of lung cancer, by regulating lipid droplet ...

Marta Morell-Castro, MD; Ilia Velez-Rodriguez, MD; Delva Rivera-Chacon, MD; Adriana Suarez-Cruz, MD; Yomayra Otero-Dominguez, MD; William Rodriguez-Cintrón, MD Background: Lung cancer is the leading ...

Bizengri received accelerated approval for NRG1 fusion-positive NSCLC and pancreatic adenocarcinoma, showing ORRs of 33% and 40%, respectively, with varying DORs. Imfinzi significantly improved ...

Lung cancer is especially dangerous because its symptoms often do not appear until the harmful cells have already spread through the body. However, there are some early warning signs you might be able ...

Lung cancer has long been associated with older male smokers, but emerging data tells a more complex story. Younger women are being diagnosed with lung cancer at higher rates than men in certain age ...